Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07822425

A Study Of Augmented Reality Real-Time Guidance With In-situ Feedback

The purpose of this study is to evaluate the feasibility and safety of using the LUMENA guidance system during clinical procedures in patients undergoing CT-guided needle Placement for kidney, liver, lymph node, abdominal mass and lung ablation/biopsy.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic

Jacksonville, Florida, 32224, United States

Location status: Recruiting

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female, ages 18-90 years
  • Patient referred to Interventional Radiology for CT-guided needle placement for ablation/biopsy.

Exclusion criteria

  • Patients who are unable to give informed consent themselves or through their parents.
  • Patients that do not fit into the gantry of the CT scanner.
  • Patients who are sensitive to radiation exposure such as pregnant women.

Treatment and study plan

LUMENA Guidance System

Device

LUMENA is an augmented reality needle guidance system that provides real-time visual guidance during CT-guided needle placement procedures.

Primary outcomes

  1. Feasibility of completing the CT-guided needle placement procedure using the LUMENA guidance system

    Time frame: 2 years

    Feasibility will be assessed as the proportion of procedures successfully completed using the LUMENA guidance system without withdrawal of the system before completion. The procedure will be considered feasible if more than 80% of procedures are completed using the system.

  2. Safety of CT-guided needle placement using the LUMENA guidance system as assessed by adverse events

    Time frame: 2 years

    Safety will be assessed by the occurrence of serious adverse events and total adverse events associated with the procedure. The safety endpoint is safe needle placement in the target without any serious adverse events and total adverse events less than 10%.

Secondary outcomes

  1. Accuracy of needle placement

    Time frame: 1 day

    Needle placement accuracy will be assessed by comparing the planned target location on the planning CT image set with the actual needle tip location on the confirmatory CT image set. Accuracy will be calculated as the three-dimensional distance between the planned target and actual needle tip location, reported in millimeters.

  2. Procedure time

    Time frame: 1 day

    Procedure time will be measured from acquisition of the initial imaging to acquisition of the final imaging and reported in minutes.

  3. Number of intermediary CT/fluoroscopy images

    Time frame: 1 day

    The number of intermediary CT/fluoroscopy images obtained during the procedure will be recorded as an indirect measure of radiation exposure.

  4. Operator usability assessment of the LUMENA guidance system

    Time frame: 1 day

    At the end of each procedure, the operator will complete a usability form that captures ease of use using a Likert scale and subjective clinical impressions of system use and utility.

Interested in participating?

Recruiting

Interested in participating?

Request Info

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Augmented Reality Real-Time Guidance With In-situ Feedback

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Sep 16, 2026
Registry last updated
Sep 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.